Summary
To investigate the incidence, the specificity and clinical significance of positivity for serum anti-neutrophil cytoplasmic antibody (ANCA) in 31 patients with systemic lupus erythematosus (SLE), the indirect immunofluorescence (IIF) technique and enzyme-linked immunosorbent assay (ELISA) were used to measure ANCA. Purified myeloperoxidase (MPO), lactoferrin (LF), cathepsin-G (CTG) and elastase (HLE) served as ANCA antigens for ELISA. Thirteen (42%) of the 31 SLE patients showed positivity for perinuclear, but not cytoplasmic, ANCA by IIF. Five of 31 sera were positive for MPO, 10 for LF, 1 for CTG and 0 for HLE by ELISA. Patients positive for ANCA had a higher score of SLE disease activity index (SLEDAI) than those without ANCA. There was no correlation between ANCA positivity, clinical manifestations, or organic involvement. While the ANCA in patients with SLE reflected disease activity, it was unrelated to organic involvement.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goeken JA. Antineutrophil cytoplasmic antibody; a useful serological marker for vasculitis. J Clin Immunol 1991; 11: 161–174.
Tervaert JWC, Limburg PC, Elema JD, Huitema MG, Horst G, The TH et al. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991; 91: 59–66.
Jennette JC, Falk RJ. Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Curr Opin Rheumatol 1992; 4: 9–15.
Kallenberg CGM, Brouwer E, Mulder AHL, Stegeman CA, Weening JJ, Tervaert JWC. ANCA; pathophysiology revisited. Clin Exp Immunol 1995; 100: 1–3.
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.
Pollak VE, Pirani CL. The kidney in systemic lupus erythematosus. In: Dubois' Lupus Erythematosus ed by Wallace, D.J., Dubois, E.L., Lea & Febiger, 1987; 105–129.
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640.
Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97 (suppl. 6): 12–13.
Rasmussen N, Sjölin C, Isaksson B, Bygren P, Wieslander J. An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA). J Immunol Methods 1990; 127: 139–145.
Nässberger L, Sjöholm AG, Jonsson H, Sturfelt G, Åkesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81: 380–383.
Gross WL, Schmitt WH, Csernok E. Antineutrophil cytoplasmic autoantibody-associated diseases: A rheumatologist's perspective. Am J Kidney Dis 1991; 18: 175, 179.
Küster S, Apenberg S, Andrassy K, Ritz E. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Contrib Nephrol 1992; 99: 94–98.
Lee SS, Lawton JMW. Antimyeloperoxidase antibody in systemic lupus erythematosus. J Intern Med 1992; 232: 283–284.
Lee SS, Lawton JWM, Chan CE, Li CS, Kwan TH, Chau KF. Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 1992; 31: 669–673.
Waldendorf, M, Schneider, M. Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Adv Exp Med Biol 1993; 336: 381–384.
Sinico, R.A., Pozzi, C., Radice, A., Tincani, A., Vecchi, M.L., Rota, S. et al. Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases. Am J Kidney Dis 1993; 22: 253–260.
Nässberger, L., Hultquist, R., Sturfelt, G. Occurrence of antilactoferrin antibodies in patients with systemic lupus erythematosus, hydralazine-induced lupus, and rheumatoid arthritis. Scand J Rheumatol 1994; 23: 206–210.
Pauzner, R., Urowitz, M., Gladman, D., Gough, J.. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J Rheumatol 1994; 21: 1670–1673.
Schnabel, A., Csernok, E., Isenberg, D.A., Mrowka, C., Gross, W.L. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum 1995; 38: 633–637.
Wong, S.N., Shah, V., Dillon, M.J. Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus. Eur J Pediatr 1995; 154: 43–45.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishiya, K., Chikazawa, H., Nishimura, S. et al. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 16, 70–75 (1997). https://doi.org/10.1007/BF02238766
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02238766